Over-exposure level Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric [PMID: 34829735] Laboratory literature summary: Over-exposure level Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric Pentadecapeptide BPC 157
It can be highly effective for wound healing, soft tissue injuries, and improving gut health

Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms

This article therefore makes the limited statement that AOD9604 is not an FDA-approved therapeutic drug in the United States and does not claim to have exhaustively verified every human or veterinary regulatory database worldwide